Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1

Journal of Experimental Medicine

Volumn 203, Issue 8, 2006, Pages 1883-1889

  Abraham, Sonya M ^a   Lawrence, Toby ^a   Kleiman, Anna ^b   Warden, Paul ^a   Medghalchi, Mino ^a   Tuckermann, Jan ^b   Saklatvala, Jeremy ^a   Clark, Andrew R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 1 ALPHA; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; GENE REPRESSION; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE MARROW; CELL CYCLE PROTEINS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; IMMEDIATE-EARLY PROTEINS; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 33746925579     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060336     Document Type: Article

References (29)

1. Newton, R. 2000. Molecular mechanisms of glucocorticoid action: what is important? Thorax. 55:603-613.
2. Adcock, I.M., and S.J. Lane. 2003. Corticosteroid-insensitive asthma: molecular mechanisms. J. Endocrinol. 178:347-355.
3. Adcock, I.M., and G. Caramori. 2001. Cross-talk between proinfl ammatory transcription factors and glucocorticoids. Immunol. Cell Biol. 79:376-384.
4. Ogawa, S., J. Lozach, C. Benner, G. Pascual, R.K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M.G. Rosenfeld, and C.K. Glass. 2005. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell. 122:707-721.
5. Reichardt, H.M., K.H. Kaestner, J. Tuckermann, O. Kretz, O. Wessely, R. Bock, P. Gass, W. Schmid, P. Herrlich, P. Angel, and G. Schutz. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 93:531-541.
6. Reichardt, H.M., J.P. Tuckermann, M. Gottlicher, M. Vujic, F. Weih, P. Angel, P. Herrlich, and G. Schutz. 2001. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20:7168-7173.
7. Tuckermann, J.P., H.M. Reichardt, R. Arribas, K.H. Richter, G. Schutz, and P. Angel. 1999. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J. Cell Biol. 147:1365-1370.
8. Schacke, H., H. Rehwinkel, and K. Asadullah. 2005. Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index. Curr. Opin. Investig. Drugs. 6:503-507.
9. Rogatsky, I., J.C. Wang, M.K. Derynck, D.F. Nonaka, D.B. Khodabakhsh, C.M. Haqq, B.D. Darimont, M.J. Garabedian, and K.R. Yamamoto. 2003. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 100:13845-13850.
10. Zhao, Q., E.G. Shepherd, M.E. Manson, L.D. Nelin, A. Sorokin, and Y. Liu. 2005. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J. Biol. Chem. 280:8101-8108.
11. Clark, A.R., and M. Lasa. 2003. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr. Opin. Pharmacol. 3:404-411.
12. Camps, M., A. Nichols, and S. Arkinstall. 2000. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14:6-16.
13. Kracht, M., and J. Saklatvala. 2002. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine. 20:91-106.
14. Clark, A.R., J.L. Dean, and J. Saklatvala. 2003. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett. 546:37-44.
15. Nimah, M., B. Zhao, A.G. Denenberg, O. Bueno, J. Molkentin, H.R. Wong, and T.P. Shanley. 2005. Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock. 23:80-87.
16. Chen, P., J. Li, J. Barnes, G.C. Kokkonen, J.C. Lee, and Y. Liu. 2002. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 169:6408-6416.
17. Hammer, M., J. Mages, H. Dietrich, A. Servatius, N. Howells, A.C. Cato, and R. Lang. 2006. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203:15-20.
18. Zhao, Q., X. Wang, L.D. Nelin, Y. Yao, R. Matta, M.E. Manson, R.S. Baliga, X. Meng, C.V. Smith, J.A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203:131-140.
19. Salojin, K.V., I.B. Owusu, K.A. Millerchip, M. Potter, K.A. Platt, and T. Oravecz. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176:1899-1907.
20. Chi, H., S.P. Barry, R.J. Roth, J.J. Wu, E.A. Jones, A.M. Bennett, and R.A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA. 103:2274-2279.
21. Dorfman, K., D. Carrasco, M. Gruda, C. Ryan, S.A. Lira, and R. Bravo. 1996. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene. 13:925-931.
22. Clark, A.R. 2003. MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J. Endocrinol. 178:5-12.
23. Swantek, J.L., M.H. Cobb, and T.D. Geppert. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell. Biol. 17:6274-6282.
24. Dai, Y., S. Datta, M. Novotny, and T.A. Hamilton. 2003. TGFβ inhibits LPS-induced chemokine mRNA stabilization. Blood. 102:1178-1185.
25. Mavropoulos, A., G. Sully, A.P. Cope, and A.R. Clark. 2005. Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells. Blood. 105:282-288.
26. Lasa, M., M. Brook, J. Saklatvala, and A.R. Clark. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21:771-780.
27. Lawrence, T., D.W. Gilroy, P.R. Colville-Nash, and D.A. Willoughby. 2001. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7:1291-1297.
28. Sousa, A.R., S.J. Lane, C. Soh, and T.H. Lee. 1999. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. J. Allergy Clin. Immunol. 104:565-574.
29. Bantel, H., M.L. Schmitz, A. Raible, M. Gregor, and K. Schulze-Osthoff. 2002. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB J. 16:1832-1834.